Total Payments
$18,823
2024 Payments
$963.25
Companies
31
Transactions
311
Medicare Patients
2,600
Medicare Billing
$409,297
Payment Breakdown by Category
Other$11,800 (62.7%)
Food & Beverage$5,107 (27.1%)
Consulting$1,500 (8.0%)
Travel$399.21 (2.1%)
Education$17.03 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $7,800 | 4 | 41.4% |
| Food and Beverage | $5,107 | 300 | 27.1% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $4,000 | 2 | 21.3% |
| Consulting Fee | $1,500 | 1 | 8.0% |
| Travel and Lodging | $399.21 | 3 | 2.1% |
| Education | $17.03 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Synergy Pharmaceuticals Inc | $8,374 | 16 | $0 (2018) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $7,092 | 82 | $0 (2024) |
| Janssen Biotech, Inc. | $895.84 | 67 | $0 (2024) |
| ABBVIE INC. | $677.14 | 42 | $0 (2024) |
| Celgene Corporation | $417.20 | 26 | $0 (2024) |
| PFIZER INC. | $358.25 | 23 | $0 (2024) |
| Allergan Inc. | $205.54 | 10 | $0 (2019) |
| Valeant Pharmaceuticals North America LLC | $158.17 | 6 | $0 (2017) |
| Romark Laboratories, LC | $98.74 | 5 | $0 (2018) |
| Stryker Corporation | $49.18 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $963.25 | 55 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($239.21) |
| 2023 | $641.63 | 39 | Celgene Corporation ($210.74) |
| 2022 | $723.43 | 46 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($235.80) |
| 2021 | $537.43 | 37 | Janssen Biotech, Inc. ($234.34) |
| 2020 | $206.64 | 14 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($118.95) |
| 2019 | $560.16 | 39 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($167.13) |
| 2018 | $12,585 | 49 | Synergy Pharmaceuticals Inc ($6,275) |
| 2017 | $2,605 | 32 | Synergy Pharmaceuticals Inc ($2,099) |
All Payment Transactions
311 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.82 | General |
| Category: Gastroenterology | ||||||
| 12/20/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: IMMUNOLOGY | ||||||
| 12/18/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/03/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.09 | General |
| Category: Gastroenterology | ||||||
| 12/03/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $11.60 | General |
| Category: Gastroenterology | ||||||
| 11/19/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: IMMUNOLOGY | ||||||
| 11/08/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: Immunology | ||||||
| 10/29/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/28/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $12.32 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: Immunology | ||||||
| 10/17/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $10.57 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/03/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: Immunology | ||||||
| 09/26/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.64 | General |
| Category: Gastroenterology | ||||||
| 09/26/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $13.81 | General |
| Category: Neuroscience | ||||||
| 08/31/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 08/28/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 08/21/2024 | EVOKE PHARMA, INC. | GIMOTI (Drug) | Food and Beverage | In-kind items and services | $23.60 | General |
| Category: Gastroenterology | ||||||
| 08/16/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $11.79 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 08/14/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/14/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $10.88 | General |
| Category: Gastroenterology | ||||||
| 08/07/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: IMMUNOLOGY | ||||||
| 08/01/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: Immunology | ||||||
| 07/30/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $11.47 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 07/25/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $11.17 | General |
| Category: Neuroscience | ||||||
| 07/18/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: ENDOCRINOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 644 | 2,659 | $277,614 | $123,085 |
| 2022 | 15 | 603 | 2,479 | $265,495 | $118,467 |
| 2021 | 22 | 802 | 2,349 | $276,171 | $107,126 |
| 2020 | 16 | 551 | 738 | $189,220 | $60,619 |
Total Patients
2,600
Total Services
8,225
Medicare Billing
$409,297
Procedure Codes
69
All Medicare Procedures & Services
69 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 92 | 1,196 | $59,800 | $41,884 | 70.0% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 92 | 678 | $33,900 | $26,577 | 78.4% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 74 | 74 | $59,792 | $13,323 | 22.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 74 | 88 | $11,440 | $7,601 | 66.4% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 32 | 207 | $15,525 | $7,214 | 46.5% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 25 | 151 | $9,362 | $5,409 | 57.8% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 49 | 49 | $31,213 | $3,771 | 12.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 53 | 57 | $5,130 | $3,328 | 64.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 25 | 25 | $4,925 | $2,885 | 58.6% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 36 | 36 | $15,732 | $2,709 | 17.2% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 14 | 14 | $8,190 | $2,335 | 28.5% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2023 | 17 | 17 | $8,449 | $1,865 | 22.1% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 14 | 17 | $3,655 | $1,590 | 43.5% |
| 76705 | Limited ultrasound scan of abdomen | Office | 2023 | 17 | 19 | $3,971 | $1,233 | 31.0% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 14 | 15 | $5,730 | $1,147 | 20.0% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2023 | 16 | 16 | $800.00 | $216.00 | 27.0% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 80 | 1,129 | $56,450 | $41,108 | 72.8% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 80 | 613 | $30,650 | $24,202 | 79.0% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 72 | 72 | $58,176 | $13,145 | 22.6% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2022 | 31 | 198 | $14,850 | $7,688 | 51.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 69 | 82 | $10,660 | $7,024 | 65.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 40 | 40 | $7,880 | $4,361 | 55.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 65 | 65 | $41,405 | $4,040 | 9.8% |
| 99487 | Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 16 | 36 | $3,996 | $3,127 | 78.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 39 | 41 | $17,917 | $3,098 | 17.3% |
About Dr. Christopher Shaver, MD
Dr. Christopher Shaver, MD is a Gastroenterology healthcare provider based in Birmingham, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1407800378.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Shaver, MD has received a total of $18,823 in payments from pharmaceutical and medical device companies, with $963.25 received in 2024. These payments were reported across 311 transactions from 31 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($7,800).
As a Medicare-enrolled provider, Shaver has provided services to 2,600 Medicare beneficiaries, totaling 8,225 services with total Medicare billing of $409,297. Data is available for 4 years (2020–2023), covering 69 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Other Specialties Gastroenterology
- Location Birmingham, AL
- Active Since 05/22/2006
- Last Updated 10/05/2010
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1407800378
Products in Payments
- Trulance (Drug) $8,374
- XIFAXAN (Drug) $6,976
- STELARA (Biological) $835.47
- ZEPOSIA (Drug) $401.50
- XELJANZ (Drug) $358.25
- UCERIS (Drug) $228.04
- Humira (Biological) $169.18
- HUMIRA (Biological) $165.15
- RINVOQ (Biological) $164.36
- LINZESS (Drug) $155.22
- Alinia Tablets 500mg 30 count bottle (Drug) $98.74
- DALVANCE (Drug) $84.69
- VIBERZI (Drug) $73.68
- TREMFYA (Drug) $60.37
- Reunion (Device) $49.18
- TRULANCE (Drug) $46.27
- CREON (Drug) $45.37
- Sucraid (Drug) $44.71
- OCALIVA (Drug) $44.39
- Cimzia (Drug) $37.78
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Birmingham
Robert Shaffer, M.d, M.D
Gastroenterology — Payments: $1.3M
Gastroenterology $1.3M
Mukul Mehra, Md, MD
Gastroenterology — Payments: $409,637
Gastroenterology $409,637
Meagan Gray, M.d, M.D
Gastroenterology — Payments: $83,600
Gastroenterology $83,600
Kirk Russ
Gastroenterology — Payments: $37,396
Gastroenterology $37,396
Kenneth Sigman, Md, MD
Gastroenterology — Payments: $34,626
Gastroenterology $34,626
Shajan Peter
Gastroenterology — Payments: $29,717
Gastroenterology $29,717